Readable HTML

French — original text

Annexe de l’Arrêté n° 2023-171/PR/MS — Liste nationale des médicaments et matériels essentiels : annexe intégrale

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

Link directly to a passage with its anchor — for example #pdf-page-3 — to open it highlighted. This reference version is generated from the authority’s publication and does not replace it. Language: French.

Contents

RÉPUBLIQUE DE DJIBOUTI MINISTÈRE DE LA SANTÉ DIRECTION DES MÉDICAMENTS, DE LA PHARMACIE ET DE LABORATOIRE (DMPL) LISTE NATIONALE DES MÉDICAMENTE ESSENTIELS PAR CLASSE THÉRAPEUTIQUE PREMIERE PARTIE : LISTE DES MÉDICAMENTS PAR CLASSE THÉRAPEUTIQUE ET PAR NIVEAU DE SOINS Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 1. ANÉSTHÉSIQUES 1.1 ANÉSTHÉSIQUES GÉNÉRAUX + OXYGENE 1.1.1 Médicaments inhalés 1 | Halothane | Inhalation | 20%. 250ml | | | | | X 2 | Isoflurane | Inhalation | 250ml/100ml | | | | | X 3 | Protoxyde d’azote | Inhalation | 100/150 bar | | | | | X 4 | Oxygène médical | Inhalation | 99% VV | | | X | X | X 5 | Sevoflurane | Inhalation | 250ml | | | | | X 6 | Hydrate Chloral | Sirop | 100mg/ml | | | | | X 7 | Air médical | Inhalation | machine ou central | | | | | X 1.1.2 Médicaments Injectables 8 | Kétamine I | Injectable | 50 mg/ml ; 10ml | | | | X | X 9 | Thiopental | Poudre injectable | 1 g/500ml | | | | | X 10 | Propofol | Injectable | 10mg/ml/20mg/ml | | | | | X 11 | Etomidate | Injectable | 20mg/10ml | | | | | X 1

djibouti-essential-list-order171-2023-annex — official PDF page 3; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 3; original table columns, symbols and diagram connections

1.2 ANESTHÉSIQUES LOCAUX 12 | Bupivacaïne | Injectable | 0.5 %; 0.25 % 20ml | | | | | X 13 | Bupivacaïne | Injection intrarachidienne | 0.5% Chlorhydrate amp 4ml à mélanger avec du glucosé à 7;5% | | | | | X 14 | Lidocaïne | Injectable | Injection 1% ; 2% (Chlorhydrate) | X | X | X | X | X 15 | Lidocaïne | Formes locales | 2% ; 5% Chlorhydrate | | X | | X | X 16 | Lidocaïne + Épinéphrine (Adrénaline) | Injectable | 1% ; 2% (Chlorhydrate ou Sulfate) + Adrénaline 1: 200 000 flacons | | | | | X 17 | Lidocaïne + Épinéphrine (Adrénaline) | Cartouches dentaires | 2 % (Chlorhydrate) + 1:80 000 (adrénaline) | | | X | X | X 18 | Ephédrine injectable | Injectable | 30mg/ml amp 1ml Chlorhydrate | | | X | X | X 19 | Phenyléphrine | Injectable | 5% /10% /2,5% | | | | | X 1.3 PRÉMÉDICATION ANESTHÉSIQUE ET SÉDATION POUR INTERVENTIONS DE COURTE DURÉE 20 | Atropine | Injectable | 1 mg/1ml | | | X | X | X 21 | Diazépam | Injectable | 10 mg/ml | | | X | X | X 22 | Diazépam | Comprimé | 5 mg | | | | | X 23 | Midazolam | Injectable | 1 mg/ml | | | | X | X 2

djibouti-essential-list-order171-2023-annex — official PDF page 4; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 4; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 2. MEDICAMENTS POUR LA DOULEUR ET LES SOINS PALLIATIFS 2.1 ANALGÉSIQUES NON OPIOIDES ET AINS 24 | Diclofenac | Injectable | 75 mg/ml | X | X | X | X | X 25 | Diclofenac | Comprimé | 25mg; 50mg | X | X | X | X | X 26 | Acide acétyl salicylique | Comprimé | 100mg; 75 mg | X | X | X | X | X 27 | Ibuprofène | Comprimé | 200 mg 400 mg | X | X | X | X | X 28 | Ibuprofène | Sirop | 100 mg/5 ml | X | X | X | X | X 29 | Paracétamol | Comprimé | 500 mg | X | X | X | X | X 30 | Paracétamol | Injectable | 500mg; 1g | X | X | X | X | X 31 | Paracétamol | Solution orale | 125mg /5mg | X | X | X | X | X 32 | Paracétamol | Suppo | 100mg; 200 mg | | | | | 2.2 ANALGÉSIQUES OPIOIDES 33 | Tramadol | Comprimé | 50mg ou 100 mg | | | | X | X 34 | Tramadol | Injectable | 50mg ou 100 mg | | | | X | X 35 | Fentanyl | Injectable | 0,1mg/2 ml 0,5mg/10 ml | | | | | X 36 | Morphine | Comprimé | Sulfate 10 mg | | | | | X 37 | Morphine | Injectable | Chlorhydrate 10 mg/ml amp 1mg | | | | | X 38 | Néfopam | Injectable | 20mg/2ml | | | X | X | X 39 | Nalbuphine | Injectable | 20mg/1ml | | | X | X | X 3

djibouti-essential-list-order171-2023-annex — official PDF page 5; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 5; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 2.3 MEDICAMENTS POUR LES AUTRES SYMPTOMES COMMUNS EN SOINS PALLIATIFS 3. ANTIALLERGIQUES/ANTIANAPHYLACTIQUES 40 | Adrénaline/Epinéphrine | Injectable | 1 mg/ml | X | X | X | X | X 41 | Chlorphéniramine | Comprimé | 4 mg | X | X | X | X | X 42 | Chlorphéniramine | Sirop | 2 mg/5 ml | X | X | X | X | X 43 | Dexaméthasone | Injectable | 4 mg | X | X | X | X | X 44 | Hydrocortisone | Injectable | 100 mg/ml | X | X | X | X | X 45 | Hydrocortisone | Comprimé | 10mg | X | X | X | X | X 46 | Prednisolone/Prednisone | Comprimé | 1 mg ou 5 mg ou 20 mg | X | X | X | X | X 47 | Betaméthasone | goutte | à préciser | | | | | 4. ANTIDOTES/TRAITEMENT DES INTOXICATIONS 4.1 ANTIDOTE NON SPECIFIQUE 48 | Charbon activé | Poudre orale | 50g ; 200g | X | X | X | X | X 4.2 ANTIDOTES SPECIFIQUES 49 | Acétylcystéine | Injectable | 200 mg/ml | | | | | X 50 | Atropine sulfate | Injectable | 1 mg/ml | | | | | X 51 | Gluconate de Calcium | Injectable | 100 mg/ml | | | X | X | X 52 | Naloxone | Injectable | 0,,4 mg/ml | | | | | X 53 | Sulfate de protamine | Injectable | 10 mg/ml | | | | | X 54 | Néostigmine | Injectable | 0,5mg/ml | | | | | X 55 | Flumazénil | Injectable | 0,1mg/ml | | | | | X 4

djibouti-essential-list-order171-2023-annex — official PDF page 6; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 6; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 5. ANTIEPILEPTIQUES/ANTICONVULSIVANTS 56 | Acide valproïque (valproate de sodium) | Comprimé | 100 mg | | | X | X | X 57 | Acide valproïque (valproate de sodium) | Comprimé | 200 mg; 500 mg | | | X | X | X 58 | Acide valproïque (valproate de sodium) | Sirop | 200mg/5ml | | | X | X | X 59 | Acide valproïque (valproate de sodium) | Liberation Prolongée L | 500mg | X | X | X | X | X 60 | Carbamazépine | Comprimé | 200 mg ou 400mg LP | | | | X | X 61 | Carbamazépine | Sirop | 100 mg/5ml | | | | X | X 62 | Diazépam | Gel Solution rectale | 5 mg/ml dans 0,5 ml; 2 ml; 4 | X | | X | X | X 63 | Diazépam | Injectable | 10 mg/ml | X | | X | X | X 64 | Phénytoine | Comprimé | 50 mg | | | | | X 65 | Phénytoine | Injectable | 50 mg/ml | | | | | X 66 | Phénobarbital | Comprimé | 50 mg ou 100 mg | X | | X | X | X 67 | Phénobarbital | Injectable | 200 mg/ml | X | | | | X 68 | Phénobarbital | Sirop | 15 mg/5 ml | X | | X | X | X 69 | Sulfate de Magnesium** | Injectable | 500 mg/10 ml ou 5g/10ml | | | X | X | X ** Indiqué pour l’éclampsie et la pré-éclampsie sévère, mais pas pour d’autres troubles convulsifs 5

djibouti-essential-list-order171-2023-annex — official PDF page 7; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 7; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSS | PS | Polyclinique | CMH | Hopitaux 6. ANTI-INFECTIEUX 6.1 ANTHELMINTHIQUES 6.1.1 Médicaments contre les helminthes intestinaux 70 | Albendazole | Comprimé à croquer | 400 mg | X | X | X | X | X 71 | Albendazole | Sirop | 200mg/5ml | X | X | X | X | X 72 | Mébendazole | Comprimé à croquer | 100 mg 500 mg | X | X | X | X | X 73 | Mébendazole | Sirop | 100mg/5ml | X | X | X | X | X 74 | Niclosamide | Comprimé à croquer | 500 mg | X | X | X | X | X 75 | Praziquantel | Comprimé à croquer | 150mg ; 600mg | X | X | X | X | X 6.1.2 Antifilarien 76 | Diethylcarbamazine(dihydrogen citrate) | Comprimé | 50 mg ; 100 mg | X | X | X | X | X 77 | Ivermectine | Comprimé | 3 mg; 12mg | X | X | X | X | X 6.1.3 Schistosomicides Antibilharziens 78 | Praziquantel | Comprimé | 600 mg | X | X | X | X | X 6

djibouti-essential-list-order171-2023-annex — official PDF page 8; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 8; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSS | PS | Polyclinique | CMH | Hopitaux 6.2 ANTIBACTERIENS 6.2.1 Antibiotiques du groupe Access 79 | Amoxicilline | Comprimé ou gélule | 250 mg; 500 mg | X | X | X | X | X 80 | Amoxicilline | Suspension | 125 mg/5 ml; 250 mg/5 ml | X | X | X | X | X 81 | Amoxicilline+Acide Clavulanique | Comprimé | 500 mg + 125 mg | X | X | X | X | X 82 | Amoxicilline+Acide Clavulanique | Suspension orale | 125 mg + 31,25 mg/5ml ; 250 mg +62,5 mg/5ml | X | X | X | X | X 83 | Amoxicilline+Acide Clavulanique | Poudre pour préparation injectable | 500mg + 100mg ; 1000mg + 200mg | X | X | X | X | X 84 | Ampicilline | Injectable | 500 mg; 1 g | X | X | X | X | X 85 | Benzathine benzylpénicilline | Poudre injectable | 1,2 M UI; 2,4 M UI | X | X | X | X | X 86 | Benzylpénicilline | Poudre injectable | 0,6 g (1 M UI) 3 g (5 M UI) | X | X | X | X | X 87 | Benzylpénicilline procaïne | Poudre injectable | 1 g (1 M UI); 3 g (3 M UI) | X | X | X | X | X 88 | Céfalexine | Comprimé | 250 mg | X | X | X | X | X 89 | Céfalexine | Suspension orale | 125 mg/5 ml; 250 mg/5 ml | X | X | X | X | X 90 | Céfazoline | Poudre injectable | 1g | | | | X | X 91 | Clindamycine | Comprimé | 150mg; 300 mg | X | X | X | X | X 92 | Clindamycine | Injectable | 150 mg/ml ; 2 ml | | | | X | X 93 | Cloxacilline | Suspension orale | 125mg/5 ml | X | X | X | X | X 7

djibouti-essential-list-order171-2023-annex — official PDF page 9; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 9; original table columns, symbols and diagram connections

94 | Cloxacilline | Comprimé ou Gélule | 250 mg; 500 mg | X | X | X | X | X 95 | Cloxacilline | Poudre pour préparation injectable | 500 mg | | | | X | X 96 | Cotrimoxazole | Comprimé | 120mg; 480mg ; 960mg | X | X | X | X | X 97 | Cotrimoxazole | Injectable | (80+16) mg/ml; 5ml et 10ml | | | | | X 98 | Cotrimoxazole | Suspension buvable | 240mg/5 ml | X | X | X | X | X 99 | Doxycycline | Comprimé | 100 mg ou 200mg | X | X | X | X | X 100 | Gentamycine | Injectable | 80mg/2ml | | | X | X | X 101 | Métronidazole | Comprimé | 250 mg ; 500 mg | X | X | X | X | X 102 | Métronidazole | Suspension buvable | 125 mg/5 ml | X | X | X | X | X 103 | Métronidazole | Ovule | 500 mg | X | X | X | X | X 104 | Métronidazole | Injectable | 500 mg/100 ml | X | X | X | X | X 105 | Nitrofurantoïne | Comprimé | 50mg; 100mg | X | X | X | X | X 106 | Phénoxyméthylpenicillin | Suspension orale | 250 mg/5 ml | X | X | X | X | X 107 | Phénoxyméthylpenicillin | Comprimé | 250 mg | X | X | X | X | X *Uniquement IST en dose unique 8

djibouti-essential-list-order171-2023-annex — official PDF page 10; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 10; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 6.2.2 Antibiotiques du groupe Watch 108 | Azithromycine* | Comprimé | 250 mg; 500 mg | X | X | X | X | X 109 | Azithromycine* | Suspension orale | 40 mg/ml | X | X | X | X | X 110 | Cefixime | Gélule | 400 mg; 200 mg | | | X | X | X 111 | Ceftriaxone | Poudre injectable | 250 mg; 1 g | | | | | X 112 | Ciprofloxacine | Comprimé | 250 mg 500mg | X | X | X | X | X 113 | Ciprofloxacine | Suspension Injectable | 400 mg/5 ml. | | | | | 114 | Levofloxacine | Suspension Injectable | 500 mg/100ml. | | | X | X | X 115 | Erythromycine | Comprimé ou gélule | 250 mg; 500 mg | X | X | X | X | X 116 | Erythromycine | Suspension orale | 125 mg/5 ml | X | X | X | X | X 117 | Imipénème + cilastatine | Injectable | 250 mg; 500 mg | | | | | X 6.2.3. Antibiotiques du groupe Reserve 118 | Vancomycine | Injectable poudre | 500 mg | | | | | X 119 | Méropénem | Poudre pour préparatio | 500mg ; 1000 mg | NON | NON | NON | X | 6.2.4. ANTILÉPREUX 120 | Clofazimine | Gélule | 50mg et 100mg | | | X | X | X 121 | Dapsone | Comprimé | 25mg-50mg et 100 mg | X | X | X | X | X 122 | Rifampicine | Comprimé | 150mg et 300 mg | X | X | X | X | X 123 | Rifampicine | Gélule | 150mg et 300 mg | X | X | X | X | X 9

djibouti-essential-list-order171-2023-annex — official PDF page 11; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 11; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 6.2.5 ANTITUBERCULEUX 124 | Ethambutol | Comprimé | 100 mg | X | X | X | X | X 125 | Isoniazid | Comprimé | 300 mg | | | | | 126 | Rifampicine + Isoniazid Pyrazinamide + Ethambutol | Comprimé | 150 mg + 75 mg + 400 mg + 275 mg | X | X | X | X | X 127 | Rifampicine + Isoniazid | Comprimé | 75 mg + 50 mg | X | X | X | X | X 128 | Rifampicine + Isoniazid | Comprimé | 150 mg + 75 mg | X | X | X | X | X 129 | Rifampicine + Isoniazid + Pyrazinamide | Comprimé | 75 mg + 50 mg +150 mg | X | X | X | X | X 6.2.5.1. Antituberculeux de réserve à utiliser pour les TB MDR et XDR par des centres spécialisés 130 | Amikacine | Injection | 500 mg | | | | | X 131 | Isoniazid | Comprimé | 100 mg | | | | | X 132 | Isoniazid | Comprimé | 300 mg | | | | | X 133 | Ethambutol | Comprimé | 400 mg | | | | | X 134 | Clofazimine | Comprimé | 100 mg | | | | | X 135 | Clofazimine | Comprimé | 50 mg | | | | | X 136 | Pyrazinamide | Comprimé | 400 mg | | | | | X 137 | Bedaquiline | Comprimé | 100 mg | | | | | X 138 | Cycloserine | Comprimé | 250 mg | | | | | 139 | Terizidone une alternative | Comprimé | 250 mg | | | | | X 140 | Delamanid | Comprimé | 50 mg | | | | | X 141 | Protionamide | Comprimé | 250 mg | | | | | X 142 | Levofloxacine | Comprimé | 500 mg | | | | | X 143 | Levofloxacine | Comprimé | 250 mg | | | | | X 144 | Linezolid | Comprimé | 600 mg | | | | | X 10

djibouti-essential-list-order171-2023-annex — official PDF page 12; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 12; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 6.3. ANTIFONGIQUES 145 | Amphotéricine B | Susp. Buv. | 50 mg/ml. | X | X | X | X | X 146 | Amphotéricine B | Poudre Injectable | 50 mg | | | | X | X 147 | Clotrimazole | Ovule gynécologique | 100 mg | X | X | X | X | X 148 | Clotrimazole | Crème avec applicateu | 1% | X | X | X | X | X 149 | Fluconazole | Gélule | 50mg | X | X | X | X | X 150 | Fluconazole | Injectable | 2mg/ml ; 100ml | | | | X | X 151 | Fluconazole | Susp. Buv. | 50 mg/ml | X | X | X | X | X 152 | Griséofulvine | Comp. ou Gélule | 250 mg | X | X | X | X | X 153 | Ketoconazole | Comp. | 200 mg | X | X | X | X | X 154 | Miconazole | Crème | 2% | X | X | X | X | X 155 | Nystatine | Comprimé Gynécologiq | 100.000 UI | X | X | X | X | X 156 | Nystatine | Comp. | 500.000 UI | X | X | X | X | X 157 | Nystatine | Susp. buv. | 100.000 UI/ml | X | X | X | X | X 6.4 ANTIVIRAUX 6.4.1 Antiherpes 158 | Aciclovir | Comp. | 200mg | X | X | X | X | X 159 | Aciclovir | Injectable | 250mg | | | | X | X 160 | Aciclovir | Crème | 5% | X | X | X | X | X 11

djibouti-essential-list-order171-2023-annex — official PDF page 13; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 13; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 6.4.2. Médicaments contre l’hépatite B 161 | Lamivudine (3TC) | Comp. | 150 mg | | | X | X | X 162 | Lamivudine (3TC) | Sirop | 50 mg/5 ml | | | X | X | X 163 | Ténofovir disoproxil fumarate | Comp. | 200 mg; 400 mg | | | X | X | X 6.4.2. Médicaments contre l’hépatite C 164 | Ribavirin | Comprimé | 200 mg; 400 mg; 600 mg | | | X | X | X 165 | Ribavirin | Injectable | 800 mg; 1 g | | | X | X | X 166 | Sofosbuvir /Velpatasvir | Comp | 400/100mg | | | X | X | X 6.4.2. Antirétroviraux 6.4.2.1. Inhibiteurs nucléosidiques et nucléotidique de la transcriptase inverse (INTI) 167 | Abacavir (ABC) | Comp. | 300 mg | X | | X | X | X 168 | Tenofovir (TDF) | Gélule | 300 mg | X | | X | X | X 169 | Zidovudine (A.Z.T.) | Comp. | 300 mg | X | | X | X | X 170 | Zidovudine (A.Z.T.) | Injectable | 200 mg/20 ml | | | X | X | X 171 | Zidovudine (A.Z.T.) | Comp. | 300 mg | | | X | X | X 172 | Zidovudine (A.Z.T.) | Sirop | 10mg/ml | | | X | X | X 173 | Lamvudine (3TC) | Sirop | 10mg/ml | | | X | X | X 6.4.2.2. Inhibiteurs non nucléosidiques de la transcriptase inverse (INNTI) 174 | Efavirenz (EFV) | Gélule | 200 mg | X | | X | X | X 175 | Efavirenz (EFV) | Comp. | 600 mg | X | | X | X | X 176 | Efavirenz (EFV) | Comp. | 400 mg | X | | X | X | X 177 | Nevirapine (NVP) | Sirop | 50 mg/5 ml | | | X | X | X 12

djibouti-essential-list-order171-2023-annex — official PDF page 14; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 14; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 6.4.2.3. Inhibiteurs de l’Integrase (INTI) 178 | Dolutegravir | Comp. | 50 MG | X | | X | X | X 179 | Dolutegravir | Comp. | 10 MG | X | | X | X | X 6.4.2.4. Inhibiteurs de protéase (IP) 180 | Atazanavir/Ritonavir (ATV/r) | Comp. | 300mg+100mg | X | | X | X | X 181 | Darunavir(DRV) | Comp. | 50 MG | X | | X | X | X 182 | Lopinavir + ritonavir (LPV/r) | Comp. | 200 mg + 50 mg | X | | X | X | X 183 | Lopinavir + ritonavir (LPV/r) | Granules | 40mg+10mg | | | X | X | X 184 | Lopinavir + ritonavir (LPV/r) | Comp. | 100+25mg | X | | X | X | X 185 | Raltégravir (RAL) | Granules | 100mg | | | X | X | X 186 | Ritonavir (RTV) | Comp. | 100 mg | X | | X | X | X 6.4.2.5. Combinaisons à dose fixe 187 | Abacavir/Lamivudine (ABC/3TC) | Comp. | 600mg+300mg | X | | X | X | X 188 | Abacavir/Lamivudine (ABC/3TC) | Comp. | 60mg+30mg | X | | X | X | X 189 | Efavirenz / Lamivudine/ Tenofovir (EFV/3T | Comp. | 400+300+300MG | X | | X | X | X 190 | Emtricitabine+Tenofovir (FTC+TDF) | Comp. | 200mg+300mg | X | | X | X | X 191 | Lamivudine/Tenofovir (3TC/TDF) | Comp. | 300mg+300mg | X | | X | X | X 192 | Lopinavir/Ritonavir (LPV/r) | Comp. | 40mg+10mg | | | X | X | X 193 | Tenofovir/Lamivudine/Dolutegravir (TDF/3T | Comp. | 300mg/300mg/50mg | X | | X | X | X 194 | Zidovudine + lamivudine (AZT/3TC) | Comp. | 60mg+30mg | X | | X | X | X 195 | Zidovudine + lamivudine (AZT/3TC) | Comp. | 300 mg + 150 mg | X | | X | X | X 196 | Zidovudine/Lamivudine (AZT/3TC) | Sirop | 10mg+10mg | | | X | X | X 13

djibouti-essential-list-order171-2023-annex — official PDF page 15; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 15; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 6.5. ANTIPROTOZOAIRES 6.5.1. Antiamibiens et antigiardiens 197 | Métronidazole | Comp. | 250 mg -500mg | X | X | X | X | X 198 | Métronidazole | Ovule | 500 mg | X | X | X | X | X 199 | Métronidazole | Injectable | 500 mg/100ml | X | | X | X | X 200 | Métronidazole | Susp. buv. | 125 mg/5ml | X | X | X | X | X 6.5.2 Antileishmaniens 201 | Antimoniate de méglumine | Injectable | 1,5 g/5ml ou 30% | | | | X | X 6.5.3. Antipaludiques 202 | Artésunate | Injectable | 60mg | X | X | X | X | X 203 | Artemether + Luméfantrine | Comp. | 20 mg + 120 mg | X | X | X | X | X 204 | Clindamycine | Comp. | 50mg | X | X | X | X | X 205 | Primaquine | Comp. | 7,5mg | X | X | X | X | X 206 | Quinine | Injectable | 100 mg/ml ; 4 ml | X | X | X | X | X 207 | Quinine | Injectable | 100 mg/ml ; 4 ml | X | X | X | X | X 6.5.4 Antipneumocystose et antitoxoplasmose 208 | Cotrimoxazole | Injectable | (80+16)mg/ml; 5ml | | | X | X | X 209 | Pyriméthamine | Comp. | 25 mg | | | X | X | X 210 | Sulfadiazine | Comprimé | 500 mg | | | X | X | X 14

djibouti-essential-list-order171-2023-annex — official PDF page 16; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 16; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 7. ANTIMIGRAINEUX (Traitement de fond de la migraine) 211 | Propranolol | Comp. | 40 mg | | | X | X | X 212 | Sumatriptan | Comp. | 12,5mg | | | X | X | X 8. ANTIPARKINSONIENS 213 | Bipéridène | Comp. | 2 et 4 mg | | | | | X 214 | Bromocriptine | Comp. | 2,5 mg | | | | | X 215 | Levodopa + (carbidopa ou benzéraside) | Comp. | 250 mg + 25 mg | | | | | X 216 | Trihexyphénidyle | Comp. | 2mg et 5 mg | | | | | X 217 | Trihexyphénidyle | Injectable | 2mg/1ml | | | | | X 9. MEDICAMENTS UTILISES EN HEMATOLOGIE 9.1. ANTIANEMIQUES 218 | Acide folique | Comp. | 5 mg | X | X | X | X | X 219 | Erythropoïétine | Injectable | 4000UI intramusculaire | | | | | X 220 | Sel ferreux | Poudre pour susp. | 125 mg/5ml | X | X | X | X | X 221 | Sel ferreux | Comp. | 60 mg | X | X | X | X | X 222 | Sel ferreux+acide folique | Comp. | 60 mg+400 µg | X | X | X | X | X 15

djibouti-essential-list-order171-2023-annex — official PDF page 17; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 17; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 9.2. MEDICAMENTS DE LA COAGULATION 223 | Acide acétylsalicylique (Aspirine) | Comp. | 100mg | X | X | X | X | X 224 | Acide tranexamique | Injectable | 500mg/5ml | | | | | X 225 | Alteplase | Injectable | 50mg | | | | | X 226 | Etamsylate | Injectable | 500mg | | | | | X 227 | Calciparine | Injectable | 5000UI/ml | | | | | X 228 | Clopidogrel | Comp. | 75 mg | | | | | X 229 | Enoxaparine | Injectable | 5000 UI/ml; 1ml. 6000UI/ml 4000UI/ml | | | | | X 230 | Heparine sodique | Injectable | 25000UI/5ml | | | | | X 231 | Phytoménadione | Injectable | 10 mg/ml; 5ml | X | X | X | X | X 232 | Warfarine | Comp. | 1 mg, 2 mg et 5 mg | X | X | X | X | X 10. DERIVES DU SANG ET SUBSTITUTS DU PLASMA 233 | Albumine | Injectable | 20% 100ml,200ml | | | | | X 234 | Immunoglobuline(anti-D et antiHépatite-B | Injectable | | | | | | X 235 | Facteurs de coagulation | Injectable | Fact 8 Fact 5 | | | | | X 11. MEDICAMENTS DE L’APPAREIL CARDIO-VASCULAIRE 11.1. ANTIANGOREUX 236 | Aténolol | Comp. | 50 mg et 100 mg | X | X | X | X | X 237 | Dinitrate d’isosorbide | Comp. Subl. | 5 mg et 10 mg | | | X | X | X 238 | Glycerine trinitrate | Comp. Subl. | 500 µg | | | | X | X 239 | Vérapamil | Comp. | 40 mg, 80 mg, 120 mg et 240 mg | | | | X | X 16

djibouti-essential-list-order171-2023-annex — official PDF page 18; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 18; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 11.2. ANTIARYTHMIQUES 238 | Amiodarone | Injectable | 150 mg | | | | | X 239 | Amiodarone | Comp. | 200 mg | | | | | X 240 | Aténolol | Comp. | 50 mg | X | X | X | X | X 241 | Digoxine | Comp. | 0,25 mg | | | | | X 242 | Digoxine | Injectable | 0,25 mg | | | | | X 243 | Vérapamil | Comp. | 40 mg, 80 mg, 120 mg et 240 mg | | | X | X | X 11.3. ANTIHYPERTENSEURS 244 | Amlodipine | Comp. | 5 mg, 10 mg | X | X | X | X | X 245 | Amlodipine + Valsartan | Comp. | 10/80 ou 10/160 | | | | X | X 246 | Aténolol | Comp. | 50 mg | X | X | X | X | X 247 | Busiprolol | Comp. | 2,5-5 et 10 mg | | | | X | X 248 | Candesartan+Hydrochlorothiazide | Comp. | 16/12,5 ou 8/12,5 | | | | X | X 249 | Candesratan | Comp. | 4mg-8mg-16mg | | | X | X | X 250 | Captopril | Comp. | 25 mg et 50 mg | X | X | X | X | X 251 | Coversyl+Amlodipin | Comp. | 10/10 ou 5/5 | | | | X | X 252 | Enalapril | Comp. | 5mg ou 10mg ou 20 mg | | | X | X | X 253 | Furosémide | Injectable | 10 mg/ml/2ml | X | X | X | X | X 254 | Furosémide | Comp. | 40 mg | X | X | X | X | X 255 | Hydralazine* | Comp. | 250 mg | X | X | X | X | X 256 | Hydrochlorothiazide | Comp. | 25 mg | X | X | X | X | X 257 | Irbesartan | Comp. | 150mg ou 300mg | | | | X | X 258 | Labtalol | Injectable | 5mg/ml | | | | | X 259 | Losartan | Comp. | 50 et 100 ml | X | X | X | X | X 260 | Méthyldopa** | Comp. | 250 mg | X | X | X | X | X 261 | Nicardipine | Comp. | 20mg ou 50 mg | X | X | X | X | X 262 | Nicardipine | Injectable | 10 mg/ml ; 10 ml | | | | X | X 263 | Nifédipine | Comp. | 10 mg | X | X | X | X | X 264 | Ramipil | Comp. | 5mg ou 10mg | X | X | X | X | X 265 | Sodium Nitroprussiate | Injectable | 50mg | | | | | X * Réservé pour l’hypertension gravidique sévère 17

djibouti-essential-list-order171-2023-annex — official PDF page 19; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 19; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 11.4. MÉDICAMENTS DE L’INSUFFISANCE CARDIAQUE 266 | Captopril | Comp. | 25 mg et 50 mg | X | X | X | X | X 267 | Digoxine | Comp. | 0,25 mg | | | X | X | X 268 | Digoxine | Injectable | 0,50 mg/2ml | | | | | X 269 | Furosémide | Inject | 10 mg/ml ; 2ml | | | | | X 270 | Hydrochlorothiazide | Comp. | 25 mg | | | | | X 271 | Spironolactone | Comp. | 25 mg | | | | | X 11.5. MEDICAMENTS CONTRE LE CHOC VASCULAIRE 272 | Dopamine | Injectable | 40mg/ml; 5ml | | | | | X 273 | Dobutamine | Injectable | 250mg/20ml | | | | | X 274 | Norédrenaline | Injectable | 250mg | | | | | X 275 | Adrénaline | Injectable | 1mg/1ml | | | | | X 276 | Isoprénaline | Injectable | 0,2mg | | | | | X 12. MEDICAMENTS DERMATOLOGIQUES 12.1. ANTIFONGIQUES 277 | Acide benzoïque+Acide salicylique | Pommade | 6% + 3% | X | X | X | X | 278 | Miconazole | Crème | 2%. | X | X | X | X | 279 | Nystatine | Crème | 100.000 UI/g. | X | X | X | X | 12.2. ANTIINFECTIEUX 280 | Acide fucidique | Pommade | | X | X | X | X | 281 | Acide fucidique | Crème | | X | X | X | X | 282 | Néomycine+Bacitracine | Pommade | 5 mg + 500 UI/g. | X | X | X | X | 283 | Permanganate de potassium | Comp. | 500 mg | X | X | X | X | X 18

djibouti-essential-list-order171-2023-annex — official PDF page 20; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 20; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 12.3.ANTIINFLAMMATOIRES/ANTIPRURIGINEUX 284 | Bétaméthasone | Pommade | 0,1%. | X | X | X | X | X 285 | Hydrocortisone | Crème | 1%. | X | X | X | X | X 12.4. ASTRINGENTS 286 | Eosine | Solution | usage extemporané | X | X | X | X | X 12.5. KERATOPLASTIQUES/KERATOLYTIQUES 287 | Vaseline salicylée (Vaseline + Acide salicyl | Pommade | 1 à 5% | X | X | X | X | X 12.6. SCABICIDES/PEDICULICIDES 288 | Benzoate de benzyle | Lotion | 25%. | X | X | X | X | X 289 | Permethrine crème | crème | 5% | X | X | X | X | X 290 | Permethrine | Lotion | 1% | X | X | X | X | X 13. PRODUITS A USAGE DIAGNOSTIC 13.1. OPHTALMOLOGIE 291 | Fluorescéine | Collyre | 1%. | | | X | X | X 292 | Fluorescéine | IV | 10% | | | X | X | X 293 | Tropicamide | Collyre | 0,5%. | | | X | X | X 294 | Cyclopentolate | Collyre | 5% | | | X | X | X 19

djibouti-essential-list-order171-2023-annex — official PDF page 21; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 21; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 13.2. PRODUITS DE CONTRASTE RADIOLOGIQUE 295 | Gadobutrol | Injectable | 1mmol/ml | | | | | X 296 | Iopamidol | Injectable | 300-647 mg/ml; 10 ml | | | | | X 297 | Iopamidol | Injectable | 300-647 mg/ml; 200 ml | | | | | X 298 | Iopromide | Injectable | 300 mg d’Iode/mL | | | | | X 299 | Sulfate de baryum | Poudre orale | 96,057 g/100 g. | | | | | X 300 | Sulfate de baryum | Poudre rectale | 400 mg | | | | | X 14. DESINFECTANTS ET ANTISEPTIQUES 14.1 ANTISEPTIQUES 301 | Cétrimide + Chlorhexidine | Sol.externe | 15% + 1,5%; | X | X | X | X | X 302 | Eau oxygénée | Sol.externe | 3% | X | X | X | X | X 303 | Ethanol dénaturé | Sol.externe | 70% | X | X | X | X | X 304 | Hypochlorite de sodium | solution | 500mg/100ml | X | X | X | X | X 305 | Permanganate de potassium | solution | 250 ml | X | X | X | X | X 306 | Polyvidone iodée | Sol. Externe(dermique | 10%. | X | X | X | X | X 14.2 DESINFECTANTS 307 | Glutaraldéhyde | Sol.externe | 2% | | | X | X | X 308 | Formol cooper stabilisé | Liquide | 40% | | | X | X | X 20

djibouti-essential-list-order171-2023-annex — official PDF page 22; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 22; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 15. DIURETIQUES 309 | Furosémide | Comp. | 40 mg | | | X | X | X 310 | Furosémide | Injectable | 10 mg/ml; 2 ml | | | X | X | X 311 | Hydrochlorothiazide | Comp. | 25 mg | | | X | X | X 312 | Mannitol | Injectable | 10%-20% | | | | | X 313 | Spironolactone | Comp. | 25 mg et 50 mg | | | X | X | X 15.1 ANTIDIURETIQUES 314 | Desmopressine | IV | 4mg/ml | | | | | X 16. MEDICAMENTS DU TUBE DIGESTIF 16.1. ANTIACIDES/ANTIULCEREUX 315 | Cimétidine | Comp. | 200 mg | X | X | X | X | X 316 | Famotidine | Injectable | 20mg/2ml | | | | | X 317 | Hydroxyde d’Aluminium | Comp. | 500 mg | X | X | X | X | X 318 | Hydroxyde d’Aluminium | Susp. buv. | 320 mg/ml | X | X | X | X | X 319 | Oméprazole | Gélule | 20 mg | X | X | X | X | X 320 | Oméprazole | Injectable | 40mg | X | X | X | X | X 16.2. ANTIEMETIQUES 321 | Métoclopramide | Comp. | 10 mg | X | X | X | X | X 322 | Métoclopramide | Sol buv/gtte | 0,1 mg/goutte | X | X | X | X | X 323 | Métoclopramide | Injectable | 5 mg/ml; 2 ml | X | X | X | X | X 324 | Métopimazine | Suppo | 5mg | X | X | X | X | X 325 | Métopimazine | Sol buv/gtte | 0.10% | X | X | X | X | X 326 | Métopimazine | Injectable | 10mg/ml | X | X | X | X | X 327 | Ondansétron | Injectable | 4mg/ml | | | X | X | X 21

djibouti-essential-list-order171-2023-annex — official PDF page 23; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 23; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 16.3. ANTIHEMORROÏDAIRES 328 | Antihémorroïdaire avec un flavonoïde | Pommade | 2% | X | X | X | X | X 329 | Anti-hémorroïdaire avec flavonoïdes (Bétamétazone/ chlorhydrate de xylocaïne/ chlorhydrate de phényléphrine) | Pommade | (5 + 25 +1) mg pour 30 g | X | X | X | X | X 330 | Anti-hémorroïdaire (acetate d’hydrocortisone+lidocaine+Oxyde de zinc+allantoine) | suppositoire | (0,25 + 0,3 + 5 + 0,5) % | | | X | X | X 16.4. ANTISPASMODIQUES 331 | Butyl hyoscine bromure | Comp. | 10 mg | X | X | X | X | X 332 | Butyl hyoscine bromure | Injectable | 20 mg; 2ml | X | X | X | X | X 333 | Phloroglucinol | Comp. | 80 mg | X | X | X | X | X 334 | Phloroglucinol | Injectable | 40 mg/4 ml | X | X | X | X | X 16.5. LAXATIFS 335 | Lactulose | sirop | 66,5%/200ml | X | X | X | X | X 336 | Bisacodyl | Comp. | 5mg | X | X | X | X | X 337 | Huile de Paraffine | flacon | 250ml | X | X | X | X | X 22

djibouti-essential-list-order171-2023-annex — official PDF page 24; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 24; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 16.6 ANTIDIARRHEIQUES 16.6.1 Réhydratation orale 338 | Racécadotril | Comp | 100mg | X | X | X | X | X 339 | Racécadotril | Sachet | 10mg | X | X | X | X | X 340 | Sels de réhydratation orale | Sachet | formule UNICEF | X | X | X | X | X 341 | Sulfate de zinc* | Comp. ou Sirop | 10 mg/unité de conditionnement | X | X | X | X | X * En cas de diarrhée aiguë, le sulfate de zinc est utilisé comme adjuvant de la réhydratation orale 16.6.2 Antidiarrhéiques symptomatiques de l’adulte 342 | Charbon activé | Comp. | 500 mg | X | X | X | X | X 343 | Codéine | Comp. | 30 mg | X | X | X | X | X 344 | Lopéramide | Gélule | 2 mg | X | X | X | X | X 23

djibouti-essential-list-order171-2023-annex — official PDF page 25; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 25; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 17. HORMONES ET AUTRES MEDICAMENTS UTILISES EN ENDOCRINOLOGIE ET CONTRACEPTIFS 17.1. CORTICOIDES 345 | Hydrocortisone | Comp. | 10mg | | | | X | X 346 | Dexaméthasone | Injectable | 4 mg/ml; 1ml | | | X | X | X 347 | Prednisolone | Comp. | 5 mg | | | X | X | X 348 | Prednisone | Comp. | 5 mg et 20 mg | | | X | X | X 17.2. CONTRACEPTIFS 17.2.1. Contraceptifs Hormonaux 349 | Acétate de medroxyprogesterone | Injectable Retard | 150mg/ml; 1ml | X | X | X | X | X 350 | Ethinylestradiol+levonorgestrel | Comp. | 30 µg + 150 µg et 30 µg +75 µg | X | X | X | X | X 351 | Ethinyloestradiol + Norgestrel | Comp. | 30 µg + 30 µg | X | X | X | X | X 352 | Levonorgestrel | Comp. | 0,075mg | X | X | X | X | X 353 | Norgestrel | Implant | 36 mg et 75 mg | X | X | X | X | X 17.2.2. Dispositifs intra uterins 354 | Dispositif contenant du cuivre | TCU 380 | | X | X | X | X | X 17.2.3. Contraceptifs mecaniques 355 | Préservatifs masculins avec ou sans spermicide | | | X | X | X | X | X 356 | Préservatifs féminins | | | X | X | X | X | X 17.3. OESTROGENES 357 | Ethinylestradiol | Comp. | 50µg | X | X | X | X | X 24

djibouti-essential-list-order171-2023-annex — official PDF page 26; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 26; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 17.4. INSULINES ET AUTRES ANTIDIABETIQUES 358 | Citagliptine plus meto(janumet) | Comp. | 500mg/1000ml | X | | X | X | X 359 | Glibenclamide | Comp. | 5mg | X | | X | X | X 360 | Glimépiride | Comp. | 2mg et 3mg | | | | | 361 | Glicagide | Comp. | 60mg | X | | X | X | X 362 | Insuline intermédiaire | Injectable | 100 UI/ml; 10ml | X | | X | X | X 363 | InsulineRapide/ Aspart | Injectable | 100 UI/ml; 10ml | X | | X | X | X 364 | Insuline Retard/Glargine | Injectable | 100 UI/ml; 10ml | X | | X | X | X 365 | Metformine | Comp. | 500 mg ; 850 mg ; 1000 mg | X | | X | X | X 17.5 INDUCTEURS D’OVULATION 366 | Clomifène | Comp. | 50 mg | X | X | X | X | X 17.6. ANTITHYROIDIENS ET THYROIDIENS 367 | Carbimazole | Comp. | 5mg | X | X | X | X | X 368 | Levothyroxine | Comp. | 0,1mg | X | X | X | X | X 369 | Levothyroxine | Comp. | 50µg | X | X | X | X | X 17.7. ANTIHYPOGLYCEMIANT 370 | Glucagon | Injectable | 1mg | | | X | X | X 17.8. HYPOLIPEMIANT 371 | Atorvastatine | Comp. | 10mg et 20mg | | | | X | X 17.9. INHIBITEUR DE LA PROLACTINE 372 | Cabergoline | Comp. | 0,5mg | | | X | X | X 25

djibouti-essential-list-order171-2023-annex — official PDF page 27; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 27; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 18. PREPARATIONS IMMUNOLOGIQUES 18.1. SERUMS 373 | Antitoxine tétanique | Injectable | 250 UI/ml; 1 ml; 2 ml | X | X | X | X | X 374 | Immunoglobuline Anti D | Injectable | 0,25mg | | | | X | X 375 | Sérum antirabique | Injectable | 150 UI/ml; 2 ml; 10 ml | | | | X | X 376 | Sérum antivenimeux | Injectable | 10ml | X | X | X | X | X 18.2. VACCINS 377 | Antiamaril | Susp. Injectable | ≥1000 UI; 0,5ml | | | X | X | X 378 | Anti Diphtérique, Coquelucheux, Tétanique | Injectable | 0,5 ml | | | X | X | X 379 | Anti Haemophilus influenzae type b | Injectable | 0,5 ml | | | X | X | X 380 | Antiméningococcique A+C ou A+C+W135 | Injectable | 0,5 ml | | | X | X | X 381 | Antipoliomyélitique (vivant atténué) | Gouttes Oral | 0,1 ml | | | X | X | X 382 | Antirabique inactivé | Injectable | 300 UI/ml, 1 ml et 300 UI/ml, 5 ml | | | X | X | X 383 | Antirougeoleux | Injectable | 0,5 ml | | | X | X | X 384 | Antitétanique | Injectable | 1500 UI/ml, 1 ml | | | X | X | X 385 | Antityphoïde polyosidique | Injectable | 0,5 mL | | | X | X | X 386 | B.C.G. | Injectable | 2-8 x 10⁵ UFC (0,05 ml et 0,1 ml) | | | X | X | X 387 | Hépatite B | Injectable | 10 µg; 20 µg | | | X | X | X 26

djibouti-essential-list-order171-2023-annex — official PDF page 28; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 28; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 19. MYORELAXANTS ET INHIBITEURS DE LA CHOLINESTERASE 388 | Atracurium | Injectable | 2,5ml/25mg ou 5ml/50mg | | | | | X 389 | Cisatracurium | Injectable | 5ml/10mg ou 10ml/20mg | | | | | X 390 | Pancuronium | Injectable | 2 mg/ml; 2ml | | | | | X 391 | Rocuronium | Injectable | 5ml/50mg | | | | | X 392 | Suxaméthonium | Injectable | 50 mg/ml ; 2ml | | | | | X 393 | Vecuronium | Poudre Injectable | 10 mg | | | | | X 20. MEDICAMENTS OPHTALMIQUES 20.1. ANTIINFECTIEUX 394 | Aciclovir | Pommade | 3% | X | X | X | X | X 395 | Gentamycine | Collyre | 0.30% | X | X | X | X | X 396 | Tétracycline | Pommade | 1% | X | X | X | X | X 20.2. ANTIINFLAMMATOIRES 397 | Dexaméthasone | Collyre | 0.10% | X | X | X | X | X 398 | Betaméthasone + néomycine | Collyre | 0,1% + 0,5% | X | X | X | X | X 399 | Indomethacin | Collyre | 1% | X | X | X | X | X 20.3.ANESTHESIQUES LOCAUX 400 | Oxybuprocaïne | Collyre | 0.40% | X | X | X | X | X 401 | Tétracaïne | Collyre | 0.50% | X | X | X | X | X 20.4. MYOTIQUES ET ANTIGLAUCOMATEUX 402 | Acétazolamide | Comp. | 250 mg | X | X | X | X | X 403 | Pilocarpine | Collyre | 2% | X | X | X | X | X 404 | Timolol | Collyre | 0.50% | X | X | X | X | X 405 | Latanoprost | Collyre | 0.005% | X | X | X | X | X 27

djibouti-essential-list-order171-2023-annex — official PDF page 29; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 29; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 20.5. MYDRIATIQUES 406 | Atropine | Collyre | 0.50% | X | X | X | X | X 407 | Tropicamide | Collyre | 0.50% | X | X | X | X | X 21. OCYTOCIQUES 408 | Ergométrine | Injectable | 200 µg/ 1ml | | | X | X | X 409 | Ergométrine | Gttes buv | 0,25 mg/ml | | | X | X | X 410 | Oxytocine | Injectable | 5 UI/ml | X | X | X | X | X 411 | Misoprostol | Comprimé | 200mcg | | | | X | X 22. NEUROLEPTIQUES ET ANTIDEPRESSEURS 22.1. MEDICAMENTS DES TROUBLES PSYCHOTIQUES 412 | Chlorpromazine | Comp. | 100 mg | X | X | X | X | X 413 | Chlorpromazine | Inject | 5 mg/ml | | | X | X | X 414 | Chlorpromazine | Injectable | 25 mg/ml; 2ml | | | X | X | X 415 | Clorazepate | Gélule | 10 mg | X | X | X | X | X 416 | Clorazepate | Inject | 10 mg/ml | | | X | X | X 417 | Fluphénazine décanoate | Injectable | 25 mg/ml; 1ml | X | X | X | X | X 418 | Halopéridol | Comp. | 5 mg | X | X | X | X | X 419 | Lévomépromazine | Comp. | 100 mg | X | X | X | X | X 420 | Lévomépromazine | Injectable | 25 mg/ml; 1ml | | | X | X | X 421 | Prométhazine | Comp. | 25 mg | X | X | X | X | X 422 | Prométhazine | Inject | 50 mg | | | X | X | X 423 | Sulpiride | Comp. | 200 mg | X | X | X | X | X 424 | Sulpiride | Inject | 50 mg/ml | | | X | X | X 28

djibouti-essential-list-order171-2023-annex — official PDF page 30; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 30; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 22.2. MEDICAMENTS DES TROUBLES DE L’HUMEUR 425 | Amitriptyline | Comp. | 25 mg | | | | | X 426 | Amitriptyline | Injectable | 25 mg/ml; 2ml | | | | | X 427 | Clomipramine | Injectable | 25 mg/ml | | | | | X 428 | Clomipramine | Gélule | 10 mg et 25 mg | | | | | X 429 | Miantserine | Comp. | 10mg et 30mg | | | | | X 430 | Olanzapine | Comp. | 10mg | | | | | X 22.3 MEDICAMENTS UTILISES DANS LES TROUBLES BIPOLAIRES 431 | Carbamazepine | Comp. | 200 mg | | | X | X | X 22.4 ANXIOLYTIQUES ET TROUBLES DU SOMMEIL 432 | Diazépam | Comp. | 5 mg | X | X | X | X | X 433 | Promethazine | Comp. | 25 mg | | | X | X | X 434 | Zolpidem | Comp. | 10 mg | | | X | X | X 435 | Clorazépate | Gélule | 10 mg | | | X | X | X 22.5 MEDICAMENTS UTILISES POUR LES ACCES DE PANIQUE 436 | Oxazepam | Comp. | 10mg et 50mg | | | X | X | X 437 | Lorazepam | Comp. | 1mg et 2,5 mg | | | X | X | X 22.6 MEDICAMENTS CORRECTEURS 438 | Tropalepine | Comp. | 10mg | | | X | X | X 439 | Trihexyphénidyle chlorhydrate | Comp. | 2 mg | | | X | X | X 29

djibouti-essential-list-order171-2023-annex — official PDF page 31; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 31; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 23. MEDICAMENTS DE L’APPAREIL RESPIRATOIRE 23.1. ANTIASTHMATIQUES 440 | Aminophylline | Injectable | 25 mg/ml; 10 ml | | | | | 441 | Béclométasone | Inhalation | 50 µg / dose | X | X | X | X | X 442 | Bromure d’ipratropium | Inhalation solution | 20µg | | | | | X 443 | Salbutamol | Comp. | 2 mg et 4 mg | X | X | X | X | X 444 | Salbutamol | Inhalation | 100 µg / dose | X | X | X | X | X 445 | Salbutamol | Injectable | 50 µg/ml ; 1 ml | | | X | X | X 446 | Salbutamol | Sirop | 2 mg/5ml | X | X | X | X | X 23.2. ANTITUSSIFS/EXPECTORANTS 447 | Carbocystéine | Sirop | 2% et 5% | X | X | X | X | X 448 | Oxomemazine | Sirop | 0,33mg/ml | X | X | X | X | X 24. SOLUTES DE REHYDRATATION, ELECTROLYTES ET MEDICAMENTS DES TROUBLES ACIDO-BASIQUES 24.1. VOIE ORALE 449 | Chlorure de Potassium | Comp. | 600mg | X | X | X | X | X 450 | Sels de réhydratation orale | Sachet | Glucose 13,5 g / NaCl 2,6 g / KCl 1,5 g / Citrate trisodique dihyd.2,9 g | X | X | X | X | X 30

djibouti-essential-list-order171-2023-annex — official PDF page 32; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 32; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire N° | DCI | Forme | Dosage | CSC | PS | Polyclinique | CMH | Hopitaux 24.2. VOIE PARENTERALE 451 | Bicarbonate de sodium | sol. Inj. | 4% | | | | X | X 452 | Chlorure de potassium | sol. Inj. | 10% | | | | X | X 453 | Chlorure de Sodium | Injectable | 10% ou 20% | | | X | X | X 454 | Chlorure de Sodium | Injectable | 0.90% | X | X | X | X | X 455 | Eau pour préparation injectables | Injectable | 2 ml, 5 ml et 10 ml | X | X | X | X | X 456 | Gélofusine | Injectable Flacon | 50ml | | | | | X 457 | Glucose | Injectable | 10% | X | X | X | X | X 458 | Glucose | Injectable | 30% et 50% | | | | | X 459 | Glucose | Injectable | 5% | X | X | X | X | X 460 | Lactate de sodium composé (Solution de R | Injectable | 500 ml | X | X | X | X | X 461 | substitut de plasma à base de NaCl et | Injectable Flacon | 0,9% / 6%; 500ml | | | | | X 25. VITAMINES ET SELS MINERAUX 462 | Acide ascorbique (Vitamine C) | Comp. | 500 mg | X | X | X | X | X 463 | Calcium gluconate | Injectable | 100mg/ml ; 10 ml | X | X | X | X | X 464 | Multivitaminé ( A, B1, B2, B3, D3) | comp. | 800 UI; 0,5 mg; 0,5 mg; 7,5 | X | X | X | X | X 465 | Rétinol (vitamine A) | Capsule | 200.000 UI | X | X | X | X | X 466 | Solution polyvitaminée ( A, B1, B2, B5, | Injectable 2 ml | 5.000 UI, 2 mg, 1,5 mg,4 mg, 2 mg, 50 mg, 1.000 UI, 2 mg | X | X | X | X | X 467 | Vitamine B1+ vitamine B6 | Comp. | 250 mg + 250 mg | X | X | X | X | X 26. ANTIRHUMATIQUES 468 | Azothioprine | Comp. | 50mg | | | X | X | X 469 | Methotrexate | Comp. | 2,5mg | | | X | X | X 470 | Methylprednisolone | Injectable | 1g | | | X | X | X 31

djibouti-essential-list-order171-2023-annex — official PDF page 33; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 33; original table columns, symbols and diagram connections

DEUXIÈME PARIE : LISTE NATIONALE DE MATERIEL E COSOMMABLES ESSENTIELS Niveau Primaire | Secondaire | Tertiaire CSC | PS | Polyclinique | CMH | Hopitaux 1. ODONTO-STOMATOLOGIE 1 | Eugénol | sol | X | X | X | X | X 2 | Oxyde de zinc léger | poudre | X | X | X | X | X 3 | Oxyde de zinc lourd | poudre | X | X | X | X | X 2. IMAGERIE MEDICALE 4 | Gel pour échographie | | | | | X | X 5 | Révélateur | sol | | | | X | X 6 | Fixateur | sol | | | | X | X 7 | Film | 18 x 24 | | | | X | X 8 | Film | 35 x 35 | | | | X | X 9 | Film | 36 x 43 | | | | X | X 10 | Film | dentaire | | | | X | X 3. BIOLOGIE 11 | Alcool | 95° | X | X | X | X | X 12 | Acétone | | | | X | X | X 13 | Acide sulfurique pur | | | | X | X | X 14 | Formol | | | | X | X | X 15 | Huile à immersion | | | | X | X | X 16 | Xylène | | | | X | X | X 17 | Bleu de méthylène poudre | | | | X | X | X 18 | Fuschine basique poudre | | | | X | X | X 19 | Fuschine de Ziehl | | | | X | X | X 20 | Violet de gentiane | | | | X | X | X 21 | Giemsa pur | | | | X | X | X 22 | May- Grünwald | | | | X | X | X 32

djibouti-essential-list-order171-2023-annex — official PDF page 34; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 34; original table columns, symbols and diagram connections

23 | Solution de Lugol | | | | X | X | X 24 | Bandelettes test glucose/protéines | | | | X | X | X 33

djibouti-essential-list-order171-2023-annex — official PDF page 35; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 35; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire CSC | PS | Polyclinique | CMH | Hopitaux 4. PETITS MATERIELS MEDICO-CHIRURGICAL 4.1 BIOLOGIE 25 | Lames de verre | 76x26 | | | X | X | X 26 | Lamelles de verre | 20x20 | | | X | X | X 27 | Ecouvillons de bactériologies stériles | | | | X | X | X 28 | Pots de prélèvements de selles | | | | X | X | X 29 | Pots de prélèvements d’urines | | | | X | X | X 30 | Tubes EDTA | | | | X | X | X 31 | Tubes secs avec bouchons | | | | X | X | X 32 | Tubes à hémolyse en verre | | | | X | X | X 33 | Tubes à hématocrite | | | | X | X | X 4.2 OBJETS DE PANSEMENT 34 | Bande de crêpe | 5m x 10cm | X | X | X | X | X 35 | Bande de gaze | 3m x 10cm | X | X | X | X | X 36 | Bande plâtrée | 3m x 10cm | X | X | X | X | X 37 | Bande plâtrée | 3m x 15cm | X | X | X | X | X 38 | Compresses stériles | 30 x 30 | X | X | X | X | X 39 | Coton hydrophile | 500 g | X | X | X | X | X 40 | Coton rouleau pour bande plâtrée | | X | X | X | X | X 41 | Pièce de gaze | 100m x 60cm | X | X | X | X | X 42 | Jersey tubulaire | 25m x 5cm | X | X | X | X | X 43 | Jersey tubulaire | 25m x 15cm | X | X | X | X | X 44 | Sparadrap perforé | 5m x 18cm | X | X | X | X | X 45 | Sparadrap perforé | 5m x 5cm | X | X | X | X | X 34

djibouti-essential-list-order171-2023-annex — official PDF page 36; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 36; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire CSC | PS | Polyclinique | CMH | Hopitaux 4.3 ARTICLE A USAGE UNIQUE 46 | Aiguille pour ponction lombaire | 22G 75 mm | X | X | X | X | X 47 | Aiguille pour rachianesthésie | 25G | | | | X | X 48 | Aiguille pour rachianesthésie | 22G | | | | X | X 49 | Aiguille épicranienne | 25G | X | X | X | X | X 50 | Aiguille épicranienne | 23G | X | X | X | X | X 51 | Aiguille épicranienne | 21G | X | X | X | X | X 52 | Seringue luer | 2 ml avec aiguille 23G | X | X | X | X | X 53 | Seringue luer | 5 ml avec aiguille 22G | X | X | X | X | X 54 | Seringue luer | 10 ml avec aiguille 21G | X | X | X | X | X 55 | Seringue à insuline 100UI/ml | avec aiguille 25G | X | X | X | X | X 56 | Cathéter court IV | 24G | X | X | X | X | X 57 | Cathéter court IV | 22G | X | X | X | X | X 58 | Cathéter court IV | 18G | X | X | X | X | X 59 | Nécessaire à perfusion | long minimum 180 cm | X | X | X | X | X 60 | Gant de protection non stérile | n° 7 | X | X | X | X | X 61 | Gant de protection non stérile | n° 8 | X | X | X | X | X 62 | Gants chirurgicaux stériles | n° 6.5 | X | X | X | X | X 63 | Gants chirurgicaux stériles | n° 7 | X | X | X | X | X 64 | Gants chirurgicaux stériles | n° 8 | X | X | X | X | X 35

djibouti-essential-list-order171-2023-annex — official PDF page 37; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 37; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire CSC | PS | Polyclinique | CMH | Hopitaux 4.4 DRAINS ET SONDES 65 | Drain thoracique | CH 28 | | | | X | X 66 | Drain thoracique | CH 32 | | | | X | X 67 | Sonde d’aspiration trachéale | CH 4 | | | | X | X 68 | Sonde d’aspiration trachéale | CH 12 | | | | X | X 69 | Sonde d’intubation trachéale | CH 3 | | | | X | X 70 | Sonde d’intubation trachéale | CH 7 | | | | X | X 71 | Sonde d’intubation trachéale | CH 7,5 | | | | X | X 72 | Sonde gastrique à double courant | CH 6 | | | | X | X 73 | Sonde gastrique à double courant | CH 12 | | | | X | X 74 | Sonde gastrique à double courant | CH 20 | | | | X | X 75 | Sonde urinaire à ballonet (Foley) | CH 12 | X | X | X | X | X 76 | Sonde urinaire à ballonet (Foley) | CH 16 | X | X | X | X | X 77 | Sonde urinaire à ballonet (Foley) | CH 18 | X | X | X | X | X 78 | Poche à urine 2 litres avec vidange | | X | X | X | X | X 4.5 FILS DE SUTURES 79 | Polyamide non résorbable monofil serti | 90cm 3/0 30mm 1/2 CT | X | X | X | X | X 80 | Polyamide non résorbable monofil serti | 90cm 2/0 30mm 1/2 CT | X | X | X | X | X 81 | Polyamide non résorbable monofil serti | 90cm 0 36mm 1/2 CT | X | X | X | X | X 82 | Polypropène non résorbable monofil | 75cm 4/0 18mm 1/2 CR | X | X | X | X | X 83 | Polypropène non résorbable monofil | 75cm 3/0 26mm 1/2 CR | X | X | X | X | X 84 | Polypropène non résorbable monofil | 75cm 2/0 30mm 1/2 CT | X | X | X | X | X 85 | Polyglycolactine résorbable tressé serti | 75cm 3/0 ; 32mm 3/8 CR | X | X | X | X | X 86 | Polyglycolactine résorbable tressé serti | 75cm 2/0 ; 32mm 3/8 CR | X | X | X | X | X 87 | Polyglycolactine résorbable tressé | 75cm 0 40mm 1/2 CR | X | X | X | X | X 36

djibouti-essential-list-order171-2023-annex — official PDF page 38; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 38; original table columns, symbols and diagram connections

serti 88 | Polyglycolactine résorbable tressé serti | 75cm 1 40mm 1/2 CR | X | X | X | X | X 89 | Polyglycolactine résorbable tressé serti | 90cm 0 30mm 3/8 CT | X | X | X | X | X 90 | Polyglycolactine résorbable tressé serti | 90cm 2 48mm 1/2 CT | X | X | X | X | X 91 | Polyglycolactine résorbable tressé | roulette 2/0 250cm | X | X | X | X | X 92 | Polyglycolactine résorbable tressé | roulette 0 250cm | X | X | X | X | X 37

djibouti-essential-list-order171-2023-annex — official PDF page 39; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 39; original table columns, symbols and diagram connections

Niveau Primaire | Secondaire | Tertiaire CSC | PS | Polyclinique | CMH | Hopitaux 4.6 PETITS MATERIELS DIVERS 93 | Abaisse langue usage unique | 14 cm | X | X | X | X | X 94 | Ciseaux de Mayo droits | 14 cm | X | X | X | X | X 95 | Ciseaux de Mayo courbes | | X | X | X | X | X 96 | Lame de bistouri | n° 21 pour manche n°4 | X | X | X | X | X 97 | Lame de bistouri | n° 23 pour manche n°4 | X | X | X | X | X 98 | Manche de Bistouri | n° 4 standard | X | X | X | X | X 99 | Pince à disséquer sans griffe droite | 12 cm | X | X | X | X | X 100 | Pince Kocher sans griffe droite | 14 cm | | | X | X | X 101 | Pince Kocher avec griffes droite | 14 cm | | | X | X | X 102 | Porte aiguille Mayo-Hegar | 15 cm | | | X | X | X 103 | Pissette en plastique | 250 ml | X | X | X | X | X 104 | Plateau à pansements inox | 30 x 15 x 5 cm | X | X | X | X | X 105 | Carton collecteur d’aiguilles | | X | X | X | X | X 106 | Garrot | | X | X | X | X | X 107 | Mètre ruban | | X | X | X | X | X 108 | Préservatif masculin | | X | X | X | X | X 109 | Thermomètre électronique | | X | X | X | X | X 38

djibouti-essential-list-order171-2023-annex — official PDF page 40; original table columns, symbols and diagram connections
djibouti-essential-list-order171-2023-annex — official PDF page 40; original table columns, symbols and diagram connections